FPXI News and Press, First Trust International IPO ETF From 08/23/22

Global Engine Group Holding Limited has filed to raise $17 million in a U.S. IPO. The firm provides ICT consulting services in Hong Kong and Taiwan. GLE is still a tiny firm operating in fragmented and highly competitive markets. I'll provide a final opinion when we learn mana...

Jupiter Neurosciences has filed updated proposed terms for a $15 million IPO. The firm is developing treatment candidates for various neuroinflammation disorders and other serious conditions. Jupiter Neurosciences is a thinly capitalized firm with no major pharma validation and is...

T20 Holdings has filed proposed terms for a $20 million U.S. IPO. The company provides design, consulting and related construction services in the natural gas and general energy space. TWEN has produced contracting revenue and profits in recent periods. I'm on Hold for the IPO...

Sacks Parente Golf has filed to raise investment via a U.S. IPO. The firm designs and manufactures golf equipment and related soft goods in the United States. SPGC is still a tiny company with unproven revenue trajectory. When we learn management's pricing and valuation assump...

MDNA Life Sciences has filed to raise development capital from a U.S. IPO. The firm is developing early stage biomarker tests for various types of cancers and endometriosis conditions. MDLS is still in regulatory and development stage for early pipeline of diagnostic tests, so the...

CW Petroleum has filed proposed terms for a $15 million U.S. IPO uplisting to Nasdaq. The company provides gas blending and distribution services in the southern U.S. region. CWPE's topline revenue has plateaued at a low level, the company operates in a low margin business and the...

Reborn Coffee has filed proposed terms for a $6 million IPO. The firm operates a small chain of coffee shops in California. REBN is a tiny company with high operating losses that is asking investors to pay a very high price for its shares at IPO. I'm on Hold for the REBN IPO d...

The global economy and financial markets have suffered a dreadful H1 2022, ravaged by a severe commodity shock, strict COVID-19 lockdowns in the world’s second-largest economy, and one of the most aggressive Fed tightening cycles in recent history. H2 looks equally tough. In it...

MAIA Biotechnology has filed proposed terms for its IPO. The firm is developing treatment candidates for various cancers. MAIA is preparing to enter Phase 2 trials (proof of concept) for its lead candidate. The firm has no well-known institutional investors, the IPO price is f...

Hesperos has filed to raise around $21 million in an IPO. The firm is developing an animal-free toxicology testing platform. HESP is still in development for its platform and has produced contracting and uneven financial results. I'll provide a final opinion when we learn more...